Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning’
CAPE TOWN, South Africa — Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday.
The results in women were published Wednesday in the New England Journal of Medicine and discussed at an AIDS conference in Munich. Gilead paid for the study and some of the researchers are company employees. Because of the surprisingly encouraging results, the study was stopped early and all participants were offered the shots, also known as lenacapavir.
“Gilead has a tool that could change the trajectory of the HIV epidemic,” said Winnie Byanyima, executive director of the Geneva-based U.N. AIDS agency.A study has shown that twice-yearly injections of a drug used to treat AIDS have been 100% effective in preventing new HIV infections in young women.She said her organization urged Gilead to share Sunlenca’s patent with a U.N.
Byanyima said the people who need long-lasting protection the most include women and girls who are victims of domestic violence and gay men in countries where same-sex relationships are criminalized. According to UNAIDS, 46% of new HIV infections globally in 2022 were in women and girls, who were three times more likely to get HIV than males in Africa.
Health Africa Aids Canada Hiv/Aids South Africa
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Experts laud injection that reportedly offers 100% protection against HIV/AIDSA study shows that a shot was 100% effective in preventing new HIV infections in women in Africa. The shot is used in the U.S. as a treatment for the virus that causes AIDS.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa. The shot is already used in the U.S. and elsewhere as a treatment for the virus that causes AIDS, and drugmaker Gilead is testing it for prevention.
Read more »